Summary & Overview

HCPCS C9770: Pars Plana Vitrectomy with Subretinal Injection

HCPCS Level II code C9770 designates a mechanical pars plana vitrectomy performed with subretinal injection of a pharmacologic or biologic agent. This vitreoretinal surgical add-on reflects advanced intraocular delivery techniques used for targeted treatment of subretinal pathology, such as inherited retinal disease therapies or localized drug delivery for retinal disorders. Nationally, the code matters as novel subretinal biologics and gene therapies expand surgical indications and billing complexity for ophthalmic practices and surgical facilities.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, expected sites of service, and the coding purpose of C9770. The publication outlines benchmark considerations, payer coverage patterns where available, and policy or billing issues relevant to this specialized surgical code.

The report provides clarity on what C9770 represents, how it fits into vitreoretinal procedure coding, and what payers and providers should consider when documenting and billing for subretinal injection procedures. Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareC9770HCPCS Level IIvitrectomypars planasubretinal injectionophthalmologyvitreoretinal surgerybiologic therapysurgical billing

Billing Code Overview

HCPCS Level II code C9770 represents vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent. This procedure involves surgical removal of the vitreous gel via a pars plana approach combined with delivery of a therapeutic agent into the subretinal space.

Service type: Ophthalmic surgical procedure (vitreoretinal surgery)
Typical site of service: Hospital outpatient department or ambulatory surgical center

Clinical & Coding Specifications

Clinical Context

A 68-year-old patient with neovascular age-related macular degeneration presents with a non-resolving subretinal hemorrhage and persistent subretinal fluid despite prior intravitreal injections. After evaluation by a vitreoretinal specialist, the decision is made to perform a pars plana vitrectomy with subretinal injection of a pharmacologic/biologic agent to displace hemorrhage and deliver medication directly to the subretinal space. Preoperative workflow includes informed consent, ocular anesthesia selection (monitored anesthesia care or general anesthesia depending on patient comorbidities), baseline visual acuity and intraocular pressure documentation, and review of systemic anticoagulation. In the operating room, a three-port pars plana vitrectomy is performed to clear vitreous hemorrhage and create access to the subretinal space. A small retinotomy or use of a microcannula is performed to deliver the pharmacologic/biologic agent into the subretinal pocket under direct visualization. Hemostasis and retinal reattachment maneuvers are performed as indicated, with intraoperative tamponade (gas or silicone oil) if necessary. Postoperative workflow includes same-day recovery, postoperative drops and positioning instructions, and scheduled follow-up visits with retinal imaging (OCT) to assess anatomical response and monitor for complications such as retinal tear, endophthalmitis, or elevated intraocular pressure.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when work or complexity substantially exceeds typical for the vitrectomy with subretinal injection.
`23`	Unusual anesthesia	Use when procedure is performed under general anesthesia for a procedure that is usually done with local/regional anesthesia.
`52`	Reduced services	Use when the procedure is partially reduced or not completed as originally planned.
`53`	Discontinued procedure	Use when the procedure is started but discontinued due to extenuating circumstances or safety concerns.
`54`	Surgical care only	Use when billing professional component for surgical care is distinct from postoperative care billed by another provider.
`55`	Postoperative management only	Use when the provider bills only for postoperative management and not the surgery.
`56`	Preoperative management only	Use when the provider bills only for preoperative evaluation and decision for surgery.
`62`	Two surgeons	Use when two surgeons work together as primary surgeons performing distinct portions of the procedure.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery	Use when an authorized non-physician clinician serves as assistant at surgery.
`CQ`	Service furnished by a resident without an attending physician present	Use when a resident provides the service independently per payer rules.
`QK`	Medical direction of two, three, or four concurrent anesthesia procedures involving qualified individuals	Use when physician directs multiple concurrent anesthesia services for the case.
`QX`	CRNA service with medical direction by a physician	Use when a CRNA furnishes anesthesia services and a physician medically directs.
`QY`	Medical direction of one CRNA by an anesthesiologist	Use when an anesthesiologist medically directs a CRNA for the case.

Taxonomy Code	Specialty	Notes
`207W00000X`	Ophthalmology	Vitreoretinal specialists or ophthalmic surgeons performing pars plana vitrectomy with subretinal injection.
`207WX0004X`	Retina/Vitreous Specialist	Subspecialty focused on surgical management of retinal disorders; most common provider for this procedure.
`2084P0800X`	Anesthesiology	Provides monitored anesthesia care or general anesthesia for ophthalmic surgery as needed.
`363LR0400X`	Physician Assistant	May assist in perioperative and intraoperative care under supervision.
`163WA0400X`	Registered Nurse First Assistant	May function as assistant at surgery in applicable settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`H35.31`	Nonexudative age-related macular degeneration	Subretinal injection may be used in management of macular disease complications or adjunctive procedures in AMD with subretinal pathology.
`H35.32`	Exudative age-related macular degeneration	Neovascular AMD with subretinal neovascularization or hemorrhage is a common indication for subretinal pharmacologic delivery during vitrectomy.
`H35.6`	Retinal hemorrhage	Subretinal hemorrhage is an indication for surgical evacuation and subretinal injection to displace or treat blood under the retina.
`H33.4`	Retinal detachment with traction or exudation	When subretinal fluid or detachment coexists, vitrectomy with subretinal injection and tamponade may be part of repair.
`H35.81`	Retinal degeneration, unspecified	Procedures to deliver biologic agents to subretinal space may be used in investigational or advanced degenerative conditions.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`67036`	Vitrectomy, mechanical, pars plana approach; complex (e.g., removal of tractional membranes, proliferative vitreoretinopathy)	May be billed for the vitrectomy portion when complexity aligns with CPT definitions; often reported when additional vitrectomy maneuvers are performed.
`67039`	Vitrectomy, mechanical, pars plana approach; for removal of vitreous opacities (e.g., vitreous hemorrhage)	May be reported when the primary indication is vitreous hemorrhage removal accompanying subretinal injection.
`67028`	Intravitreal injection of a pharmacologic agent (separate procedure from vitrectomy)	Used when an intravitreal injection is performed in addition to or instead of subretinal delivery; documents alternate routes of administration.
`67113`	Repair of retinal detachment; complex (with vitrectomy, fluid-gas exchange, and internal tamponade)	Reported when the vitrectomy with subretinal injection includes detachment repair techniques and internal tamponade.
`65778`	Transplantation procedures involving ocular tissues (e.g., amniotic membrane) — (example code for anterior segment; included here as occasionally performed adjunctively)	May be performed as an adjunct in complex cases requiring ocular surface or anterior segment interventions during the same operative episode.